Clinical Trial Update: The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus [Phase 4]

View source ↗

Summary

The REALITY Phase 4 trial compared Cypher and Taxus paclitaxel-eluting stents in patients with coronary artery disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher (sirolimus-eluting coronary stent)
• TAXUS (paclitaxel-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED